Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A green and environmentally friendly route of no
thinning
agent was designed to prepare
sebacic acid
. Sodium ricinoleate was selected as the raw material to carry out solid-phase cleavage in a tubular furnace. The reaction parameters including catalyst, ratio of sodium ricinoleate/KOH, reaction time, reaction temperature, and absolute pressure were optimized to obtain a high yield of
sebacic acid
. A satisfactory yield (70.2%) of
sebacic acid
was received in the presence of 1% catalyst (Fe
2
O
3
) by weight (w/w), with 5:4 (w/w) ratio of sodium ricinoleate/KOH at 543 K under the absolute pressure of 0.09 MPa in 60 min. Sebacic acid was identified by gas chromatography analysis, and the purity (98.1%) of the product was further assessed by its melting point (306.3 K). Alkaline enhancement generates a better cracking effect. The yield of
sebacic acid
can be improved by a certain absolute pressure as a result of avoiding oxidation of sodium ricinoleate as well as reducing the residence time of hydrogen.
...
PMID:Green Process without Thinning Agents for Preparing Sebacic Acid via Solid-Phase Cleavage. 3145 96
